Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Michael Kastan

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Chemicals & Drugs

Physiology

Genes & Molecular Sequences

p53 Genes

Phenomena

Anatomy

Concepts & Ideas

G1 Phase

Living Beings

Mice

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
21
Canman, Christine
9
Civin, Curt
9
Bakkenist, Christopher
9
Lim, Dae-Sik
7
Kim, Seong-Tae
6
Gilmer, Tona
6
Xu, Bo
5
Morgan, SE
5
Gore, Steven
4
Kitagawa, Risa
4
Maclean, Kirsteen
4
Bartek, Jiri
4
Fornace, Albert
4
Shiloh, Yosef
4
Zhan, Qimin

Sign-in to see all Coauthors

Publications

TOP 3
Ofir-Rosenfeld Yaara; Boggs Kristy; Michael Dan; Kastan Michael B; Oren Moshe
Mdm2 regulates p53 mRNA translation through inhibitory interactions with ribosomal protein L26.
Rainey Michael D; Charlton Maura E; Stanton Robert V; Kastan Michael B
Transient inhibition of ATM kinase is sufficient to enhance cellular sensitivity to ionizing radiation.
Chandhasin Chandtip; Ducu Razvan I; Berkovich Elijahu; Kastan Michael B; Marriott Susan J
Human T-cell leukemia virus type 1 tax attenuates the ATM-mediated cellular DNA damage response.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Michael Kastan (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2008: Ofir-Rosenfeld Yaara; Boggs Kristy; Michael Dan; Kastan Michael B; Oren Moshe
Mdm2 regulates p53 mRNA translation through inhibitory interactions with ribosomal protein L26.
Molecular cell 2008;32(2):180-9.
2008: Rainey Michael D; Charlton Maura E; Stanton Robert V; Kastan Michael B
Transient inhibition of ATM kinase is sufficient to enhance cellular sensitivity to ionizing radiation.
Cancer research 2008;68(18):7466-74.
2008: Chandhasin Chandtip; Ducu Razvan I; Berkovich Elijahu; Kastan Michael B; Marriott Susan J
Human T-cell leukemia virus type 1 tax attenuates the ATM-mediated cellular DNA damage response.
Journal of virology 2008;82(14):6952-61.
2008: Kastan Michael B
DNA damage responses: mechanisms and roles in human disease: 2007 G.H.A. Clowes Memorial Award Lecture.
Molecular cancer research : MCR 2008;6(4):517-24.
2008: Tang Xi; Hui Zhou-Guang; Cui Xiao-Li; Garg Renu; Kastan Michael B; Xu Bo
A novel ATM-dependent pathway regulates protein phosphatase 1 in response to DNA damage.
Molecular and cellular biology 2008;28(8):2559-66.
2008: Maclean Kirsteen H; Dorsey Frank C; Cleveland John L; Kastan Michael B
Targeting lysosomal degradation induces p53-dependent cell death and prevents cancer in mouse models of lymphomagenesis.
The Journal of clinical investigation 2008;118(1):79-88.
2008: Berkovich Elijahu; Monnat Raymond J; Kastan Michael B
Assessment of protein dynamics and DNA repair following generation of DNA double-strand breaks at defined genomic sites.
Nature protocols 2008;3(5):915-22.
2007: Loehberg Christian R; Thompson Tiia; Kastan Michael B; Maclean Kirsteen H; Edwards Dean G; Kittrell Frances S; Medina Daniel; Conneely Orla M; O'Malley Bert W
Ataxia telangiectasia-mutated and p53 are potential mediators of chloroquine-induced resistance to mammary carcinogenesis.
Cancer research 2007;67(24):12026-33.
2007: Kastan Michael B
Our cells get stressed too! Implications for human disease.
Blood cells, molecules & diseases 2007;39(2):148-50.
2007: Maclean Kirsteen H; Kastan Michael B; Cleveland John L
Atm deficiency affects both apoptosis and proliferation to augment Myc-induced lymphomagenesis.
Molecular cancer research : MCR 2007;5(7):705-11.
2007: Berkovich Elijahu; Monnat Raymond J; Kastan Michael B
Roles of ATM and NBS1 in chromatin structure modulation and DNA double-strand break repair.
Nature cell biology 2007;9(6):683-90.
2007: Kastan Michael B; Berkovich Elijahu
p53: a two-faced cancer gene.
Nature cell biology 2007;9(5):489-91.
2007: Kastan Michael B
Wild-type p53: tumors can't stand it.
Cell 2007;128(5):837-40.
2006: Schneider Jochen G; Finck Brian N; Ren Jie; Standley Kara N; Takagi Masatoshi; Maclean Kirsteen H; Bernal-Mizrachi Carlos; Muslin Anthony J; Kastan Michael B; Semenkovich Clay F
ATM-dependent suppression of stress signaling reduces vascular disease in metabolic syndrome.
Cell metabolism 2006;4(5):377-89.
2006: Sandlund John T; Kastan Michael B; Kennedy Wren; Behm Frederick; Entrekin Elaine; Pui Ching-Hon; Kalwinsky David T; Raimondi Susana C
A subtle t(3;8) results in plausible juxtaposition of MYC and BCL6 in a child with Burkitt lymphoma/leukemia and ataxia-telangiectasia.
Cancer genetics and cytogenetics 2006;168(1):69-72.
2006: Bekker-Jensen Simon; Lukas Claudia; Kitagawa Risa; Melander Fredrik; Kastan Michael B; Bartek Jiri; Lukas Jiri
Spatial organization of the mammalian genome surveillance machinery in response to DNA strand breaks.
The Journal of cell biology 2006;173(2):195-206.
2005: Morales Monica; Theunissen Jan-Willem F; Kim Carla F Bender; Kitagawa Risa; Kastan Michael B; Petrini John H J
The Rad50S allele promotes ATM-dependent DNA damage responses and suppresses ATM deficiency: implications for the Mre11 complex as a DNA damage sensor.
Genes & development 2005;19(24):3043-54.
2005: Kastan Michael B
Cell biology: A BID for the pathway.
Nature 2005;437(7062):1103.
2005: Takagi Masatoshi; Absalon Michael J; McLure Kevin G; Kastan Michael B
Regulation of p53 translation and induction after DNA damage by ribosomal protein L26 and nucleolin.
Cell 2005;123(1):49-63.
2005: Bartkova Jirina; Bakkenist Christopher J; Rajpert-De Meyts Ewa; Skakkebaek Niels E; Sehested Maxwell; Lukas Jiri; Kastan Michael B; Bartek Jiri
ATM activation in normal human tissues and testicular cancer.
Cell cycle (Georgetown, Tex.) 2005;4(6):838-45.
2005: Kitagawa R; Kastan M B
The ATM-dependent DNA damage signaling pathway.
Cold Spring Harbor symposia on quantitative biology 2005;70():99-109.
2004: Kastan Michael B; Bartek Jiri
Cell-cycle checkpoints and cancer.
Nature 2004;432(7015):316-23.
2004: McLure Kevin G; Takagi Masatoshi; Kastan Michael B
NAD+ modulates p53 DNA binding specificity and function.
Molecular and cellular biology 2004;24(22):9958-67.
2004: Karlseder Jan; Hoke Kristina; Mirzoeva Olga K; Bakkenist Christopher; Kastan Michael B; Petrini John H J; de Lange Titia
The telomeric protein TRF2 binds the ATM kinase and can inhibit the ATM-dependent DNA damage response.
PLoS biology 2004;2(8):E240.
2004: Arlt Martin F; Xu Bo; Durkin Sandra G; Casper Anne M; Kastan Michael B; Glover Thomas W
BRCA1 is required for common-fragile-site stability via its G2/M checkpoint function.
Molecular and cellular biology 2004;24(15):6701-9.
2004: Bakkenist Christopher J; Kastan Michael B
Phosphatases join kinases in DNA-damage response pathways.
Trends in cell biology 2004;14(7):339-41.
2004: Bakkenist Christopher J; Kastan Michael B
Initiating cellular stress responses.
Cell 2004;118(1):9-17.
2004: Garg Renu; Callens Shannon; Lim Dae-Sik; Canman Christine E; Kastan Michael B; Xu Bo
Chromatin association of rad17 is required for an ataxia telangiectasia and rad-related kinase-mediated S-phase checkpoint in response to low-dose ultraviolet radiation.
Molecular cancer research : MCR 2004;2(6):362-9.
2004: Surrallés Jordi; Jackson Stephen P; Jasin Maria; Kastan Michael B; West Stephen C; Joenje Hans
Molecular cross-talk among chromosome fragility syndromes.
Genes & development 2004;18(12):1359-70.
2004: Kitagawa Risa; Bakkenist Christopher J; McKinnon Peter J; Kastan Michael B
Phosphorylation of SMC1 is a critical downstream event in the ATM-NBS1-BRCA1 pathway.
Genes & development 2004;18(12):1423-38.
2004: Bakkenist Christopher J; Drissi Rachid; Wu Jing; Kastan Michael B; Dome Jeffrey S
Disappearance of the telomere dysfunction-induced stress response in fully senescent cells.
Cancer research 2004;64(11):3748-52.
2004: Horejsí Zuzana; Falck Jacob; Bakkenist Christopher J; Kastan Michael B; Lukas Jiri; Bartek Jiri
Distinct functional domains of Nbs1 modulate the timing and magnitude of ATM activation after low doses of ionizing radiation.
Oncogene 2004;23(17):3122-7.
2004: Xu Bo; Kastan Michael B
Analyzing cell cycle checkpoints after ionizing radiation.
Methods in molecular biology (Clifton, N.J.) 2004;281():283-92.
2003: Cortés M L; Bakkenist C J; Di Maria M V; Kastan M B; Breakefield X O
HSV-1 amplicon vector-mediated expression of ATM cDNA and correction of the ataxia-telangiectasia cellular phenotype.
Gene therapy 2003;10(16):1321-7.
2003: Lee Joo Hyeon; Xu Bo; Lee Chang-Hun; Ahn Jun-Young; Song Min Sup; Lee Ho; Canman Christine E; Lee Jong-Soo; Kastan Michael B; Lim Dae-Sik
Distinct functions of Nijmegen breakage syndrome in ataxia telangiectasia mutated-dependent responses to DNA damage.
Molecular cancer research : MCR 2003;1(9):674-81.
2003: Bakkenist Christopher J; Kastan Michael B
DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation.
Nature 2003;421(6922):499-506.
2003: Kastan Michael B; Zambetti Gerard P
Parc-ing p53 in the cytoplasm.
Cell 2003;112(1):1-2.
2002: Nakanishi Koji; Taniguchi Toshiyasu; Ranganathan Velvizhi; New Helen V; Moreau Lisa A; Stotsky Maria; Mathew Christopher G; Kastan Michael B; Weaver David T; D'Andrea Alan D
Interaction of FANCD2 and NBS1 in the DNA damage response.
Nature cell biology 2002;4(12):913-20.
2002: Xu Bo; O'Donnell Anne H; Kim Seong-Tae; Kastan Michael B
Phosphorylation of serine 1387 in Brca1 is specifically required for the Atm-mediated S-phase checkpoint after ionizing irradiation.
Cancer research 2002;62(16):4588-91.
2002: Taniguchi Toshiyasu; Garcia-Higuera Irene; Xu Bo; Andreassen Paul R; Gregory Richard C; Kim Seong-Tae; Lane William S; Kastan Michael B; D'Andrea Alan D
Convergence of the fanconi anemia and ataxia telangiectasia signaling pathways.
Cell 2002;109(4):459-72.
2002: Kim Seong-Tae; Xu Bo; Kastan Michael B
Involvement of the cohesin protein, Smc1, in Atm-dependent and independent responses to DNA damage.
Genes & development 2002;16(5):560-70.
2002: Xu Bo; Kim Seong-Tae; Lim Dae-Sik; Kastan Michael B
Two molecularly distinct G(2)/M checkpoints are induced by ionizing irradiation.
Molecular and cellular biology 2002;22(4):1049-59.
2001: Xu B; Kim St; Kastan M B
Involvement of Brca1 in S-phase and G(2)-phase checkpoints after ionizing irradiation.
Molecular and cellular biology 2001;21(10):3445-50.
2001: Kastan M B; Lim D S; Kim S T; Yang D
ATM--a key determinant of multiple cellular responses to irradiation.
Acta oncologica (Stockholm, Sweden) 2001;40(6):686-8.
2001: Shiloh Y; Kastan M B
ATM: genome stability, neuronal development, and cancer cross paths.
Advances in cancer research 2001;83():209-54.
2000: Yang D Q; Kastan M B
Participation of ATM in insulin signalling through phosphorylation of eIF-4E-binding protein 1.
Nature cell biology 2000;2(12):893-8.
2000: Lim D S; Kim S T; Xu B; Maser R S; Lin J; Petrini J H; Kastan M B
ATM phosphorylates p95/nbs1 in an S-phase checkpoint pathway.
Nature 2000;404(6778):613-7.
2000: Pandita T K; Lieberman H B; Lim D S; Dhar S; Zheng W; Taya Y; Kastan M B
Ionizing radiation activates the ATM kinase throughout the cell cycle.
Oncogene 2000;19(11):1386-91.
2000: Kastan M B; Lim D S; Kim S T; Xu B; Canman C
Multiple signaling pathways involving ATM.
Cold Spring Harbor symposia on quantitative biology 2000;65():521-6.
2000: Ziv Y; Banin S; Lim D S; Canman C E; Kastan M B; Shiloh Y
Expression and assay of recombinant ATM.
Methods in molecular biology (Clifton, N.J.) 2000;99():99-108.
1999: Kim S T; Lim D S; Canman C E; Kastan M B
Substrate specificities and identification of putative substrates of ATM kinase family members.
The Journal of biological chemistry 1999;274(53):37538-43.
1999: DiGiuseppe J A; Weng L J; Yu K H; Fu S; Kastan M B; Samid D; Gore S D
Phenylbutyrate-induced G1 arrest and apoptosis in myeloid leukemia cells: structure-function analysis.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1999;13(8):1243-53.
1999: DiGiuseppe J A; Kastan M B; Weng L J; Gore S D
Cytoprotective effects of hematopoietic growth factors on primary human acute myeloid leukemias are not mediated through changes in BCL-2, bax, or p21WAF1/CIP1.
In vivo (Athens, Greece) 1999;13(1):1-6.
1998: Westphal C H; Hoyes K P; Canman C E; Huang X; Kastan M B; Hendry J H; Leder P
Loss of atm radiosensitizes multiple p53 null tissues.
Cancer research 1998;58(24):5637-9.
1998: Rhodes N; D'Souza T; Foster C D; Ziv Y; Kirsch D G; Shiloh Y; Kastan M B; Reinhart P H; Gilmer T M
Defective potassium currents in ataxia telangiectasia fibroblasts.
Genes & development 1998;12(23):3686-92.
1998: Kirsch D G; Kastan M B
Tumor-suppressor p53: implications for tumor development and prognosis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(9):3158-68.
1998: Canman C E; Lim D S; Cimprich K A; Taya Y; Tamai K; Sakaguchi K; Appella E; Kastan M B; Siliciano J D
Activation of the ATM kinase by ionizing radiation and phosphorylation of p53.
Science (New York, N.Y.) 1998;281(5383):1677-9.
1998: Lim D S; Kirsch D G; Canman C E; Ahn J H; Ziv Y; Newman L S; Darnell R B; Shiloh Y; Kastan M B
ATM binds to beta-adaptin in cytoplasmic vesicles.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(17):10146-51.
1998: Canman C E; Kastan M B
Small contribution of G1 checkpoint control manipulation to modulation of p53-mediated apoptosis.
Oncogene 1998;16(8):957-66.
1997: Siliciano J D; Canman C E; Taya Y; Sakaguchi K; Appella E; Kastan M B
DNA damage induces phosphorylation of the amino terminus of p53.
Genes & development 1997;11(24):3471-81.
1997: Smilenov L B; Morgan S E; Mellado W; Sawant S G; Kastan M B; Pandita T K
Influence of ATM function on telomere metabolism.
Oncogene 1997;15(22):2659-65.
1997: Agani F; Kirsch D G; Friedman S L; Kastan M B; Semenza G L
p53 does not repress hypoxia-induced transcription of the vascular endothelial growth factor gene.
Cancer research 1997;57(20):4474-7.
1997: Metcalfe S M; Canman C E; Milner J; Morris R E; Goldman S; Kastan M B
Rapamycin and p53 act on different pathways to induce G1 arrest in mammalian cells.
Oncogene 1997;15(14):1635-42.
1997: Morgan S E; Kastan M B
Dissociation of radiation-induced phosphorylation of replication protein A from the S-phase checkpoint.
Cancer research 1997;57(16):3386-9.
1997: DiGiuseppe J A; Kastan M B
Apoptosis in haematological malignancies.
Journal of clinical pathology 1997;50(5):361-4.
1997: Baskaran R; Wood L D; Whitaker L L; Canman C E; Morgan S E; Xu Y; Barlow C; Baltimore D; Wynshaw-Boris A; Kastan M B; Wang J Y
Ataxia telangiectasia mutant protein activates c-Abl tyrosine kinase in response to ionizing radiation.
Nature 1997;387(6632):516-9.
1997: Morgan S E; Lovly C; Pandita T K; Shiloh Y; Kastan M B
Fragments of ATM which have dominant-negative or complementing activity.
Molecular and cellular biology 1997;17(4):2020-9.
1997: Canman C E; Kastan M B
Role of p53 in apoptosis.
Advances in pharmacology (San Diego, Calif.) 1997;41():429-60.
1997: Morgan S E; Kastan M B
p53 and ATM: cell cycle, cell death, and cancer.
Advances in cancer research 1997;71():1-25.
1996: Canman C E; Kastan M B
Signal transduction. Three paths to stress relief.
Nature 1996;384(6606):213-4.
1996: Pandita T K; Hall E J; Hei T K; Piatyszek M A; Wright W E; Piao C Q; Pandita R K; Willey J C; Geard C R; Kastan M B; Shay J W
Chromosome end-to-end associations and telomerase activity during cancer progression in human cells after treatment with alpha-particles simulating radon progeny.
Oncogene 1996;13(7):1423-30.
1996: Chen C Y; Hall I; Lansing T J; Gilmer T M; Tlsty T D; Kastan M B
Separate pathways for p53 induction by ionizing radiation and N-(phosphonoacetyl)-L-aspartate.
Cancer research 1996;56(16):3659-62.
1996: Inaba T; Inukai T; Yoshihara T; Seyschab H; Ashmun R A; Canman C E; Laken S J; Kastan M B; Look A T
Reversal of apoptosis by the leukaemia-associated E2A-HLF chimaeric transcription factor.
Nature 1996;382(6591):541-4.
1996: Goldman S C; Chen C Y; Lansing T J; Gilmer T M; Kastan M B
The p53 signal transduction pathway is intact in human neuroblastoma despite cytoplasmic localization.
The American journal of pathology 1996;148(5):1381-5.
1995: Kilpatrick K E; Carrier F; Smith M L; Chen C Y; Lee A J; Rusnak D W; Kastan M B; Fornace A J; Champion B R; Gilmer T M
The production and characterization of murine monoclonal antibodies to human Gadd45 raised against a recombinant protein.
Hybridoma 1995;14(4):355-9.
1995: Canman C E; Gilmer T M; Coutts S B; Kastan M B
Growth factor modulation of p53-mediated growth arrest versus apoptosis.
Genes & development 1995;9(5):600-11.
1995: Kastan M B; Canman C E; Leonard C J
P53, cell cycle control and apoptosis: implications for cancer.
Cancer metastasis reviews 1995;14(1):3-15.
1995: Canman C E; Kastan M B
Induction of apoptosis by tumor suppressor genes and oncogenes.
Seminars in cancer biology 1995;6(1):17-25.
1995: Leonard C J; Canman C E; Kastan M B
The role of p53 in cell-cycle control and apoptosis: implications for cancer.
Important advances in oncology 1995;():33-42.
1994: Smith M L; Chen I T; Zhan Q; Bae I; Chen C Y; Gilmer T M; Kastan M B; O'Connor P M; Fornace A J
Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen.
Science (New York, N.Y.) 1994;266(5189):1376-80.
1994: Canman C E; Wolff A C; Chen C Y; Fornace A J; Kastan M B
The p53-dependent G1 cell cycle checkpoint pathway and ataxia-telangiectasia.
Cancer research 1994;54(19):5054-8.
1994: Slebos R J; Lee M H; Plunkett B S; Kessis T D; Williams B O; Jacks T; Hedrick L; Kastan M B; Cho K R
p53-dependent G1 arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(12):5320-4.
1994: Zhan Q; Bae I; Kastan M B; Fornace A J
The p53-dependent gamma-ray response of GADD45.
Cancer research 1994;54(10):2755-60.
1994: Chen C Y; Oliner J D; Zhan Q; Fornace A J; Vogelstein B; Kastan M B
Interactions between p53 and MDM2 in a mammalian cell cycle checkpoint pathway.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(7):2684-8.
1994: Nelson W G; Kastan M B
DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways.
Molecular and cellular biology 1994;14(3):1815-23.
1994: Canman C E; Chen C Y; Lee M H; Kastan M B
DNA damage responses: p53 induction, cell cycle perturbations, and apoptosis.
Cold Spring Harbor symposia on quantitative biology 1994;59():277-86.
1993: Kastan M B; Kuerbitz S J
Control of G1 arrest after DNA damage.
Environmental health perspectives 1993;101 Suppl 5():55-8.
1993: Slichenmyer W J; Nelson W G; Slebos R J; Kastan M B
Loss of a p53-associated G1 checkpoint does not decrease cell survival following DNA damage.
Cancer research 1993;53(18):4164-8.
1993: Craig R W; Buchan H L; Civin C I; Kastan M B
Altered cytoplasmic/nuclear distribution of the c-myc protein in differentiating ML-1 human myeloid leukemia cells.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1993;4(5):349-57.
1993: Kessis T D; Slebos R J; Nelson W G; Kastan M B; Plunkett B S; Han S M; Lorincz A T; Hedrick L; Cho K R
Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(9):3988-92.
1992: Kastan M B; Zhan Q; el-Deiry W S; Carrier F; Jacks T; Walsh W V; Plunkett B S; Vogelstein B; Fornace A J
A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia.
Cell 1992;71(4):587-97.
1992: Kuerbitz S J; Plunkett B S; Walsh W V; Kastan M B
Wild-type p53 is a cell cycle checkpoint determinant following irradiation.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(16):7491-5.
1991: Kastan M B; Onyekwere O; Sidransky D; Vogelstein B; Craig R W
Participation of p53 protein in the cellular response to DNA damage.
Cancer research 1991;51(23 Pt 1):6304-11.
1991: Kastan M B; Radin A I; Kuerbitz S J; Onyekwere O; Wolkow C A; Civin C I; Stone K D; Woo T; Ravindranath Y; Craig R W
Levels of p53 protein increase with maturation in human hematopoietic cells.
Cancer research 1991;51(16):4279-86.
1991: Kaufmann S H; McLaughlin S J; Kastan M B; Liu L F; Karp J E; Burke P J
Topoisomerase II levels during granulocytic maturation in vitro and in vivo.
Cancer research 1991;51(13):3534-43.
1991: Gore S D; Kastan M B; Civin C I
Normal human bone marrow precursors that express terminal deoxynucleotidyl transferase include T-cell precursors and possible lymphoid stem cells.
Blood 1991;77(8):1681-90.
1990: Gore S D; Kastan M B; Goodman S N; Civin C I
Detection of minimal residual T cell acute lymphoblastic leukemia by flow cytometry.
Journal of immunological methods 1990;132(2):275-86.
1990: Gore S; Kastan M; Civin C
Flow cytometric identification of intracellular antigens: detection of minimal residual leukemia.
Bone marrow transplantation 1990;6 Suppl 1():39-41.
1990: Kastan M B; Schlaffer E; Russo J E; Colvin O M; Civin C I; Hilton J
Direct demonstration of elevated aldehyde dehydrogenase in human hematopoietic progenitor cells.
Blood 1990;75(10):1947-50.
1989: Kastan M B; Stone K D; Civin C I
Nuclear oncoprotein expression as a function of lineage, differentiation stage, and proliferative status of normal human hematopoietic cells.
Blood 1989;74(5):1517-24.
1989: Kastan M B; Slamon D J; Civin C I
Expression of protooncogene c-myb in normal human hematopoietic cells.
Blood 1989;73(6):1444-51.
1989: Kastan M B; Strauss L C; Civin C I
The role of hematopoietic growth factors and oncogenes in leukemogenesis.
The American journal of pediatric hematology/oncology 1989;11(3):249-67.
1989: Kastan M B; Zehnbauer B A; Leventhal B G; Corden B J; Dover G J
Philadelphia-chromosome positive essential thrombocythemia. Two cases in children.
The American journal of pediatric hematology/oncology 1989;11(4):433-6.

Sign-in to see more